Apogee Therapeutics (APGE) Q2 2026 Earnings

11MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.22
-1.13
-1.04
-0.95

Details

Expected EPS
-1.066253
Actual EPS
-1.06
Surprise EPS
0.01
Surprise Percent
+0.59%

Description

Apogee Therapeutics (APGE) has reported earnings of -1.06 per share for Q2 2026.

0 Comments

Share your thoughts